4.8 Article

Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

Journal

CANCER CELL
Volume 7, Issue 6, Pages 575-589

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2005.05.007

Keywords

-

Funding

  1. NCI NIH HHS [CA 09299, P0-1 CA99031, R0-1 CA109311, P20 CA101936, CA16672] Funding Source: Medline
  2. PHS HHS [P50 83639] Funding Source: Medline

Ask authors/readers for more resources

Epidermal growth factor receptor (EGFR) exists in the nucleus of highly proliferative cells where it functions as a transcription factor. Although EGFR has transactivational activity, it lacks a DNA binding domain and, therefore, may require a DNA binding transcription cofactor for its transcriptional function. Here, we report that EGFR physically interacts with signal transducers and activators of transcription 3 (STAT3) in the nucleus, leading to transcriptional activation of inducible nitric oxide synthase (iNOS). In breast carcinomas, nuclear EGFR positively correlates with iNOS. This study describes a mode of transcriptional control involving cooperated efforts of STAT3 and nuclear EGFR. Our work suggests that the deregulated iNOS/NO pathway may partly contribute to the malignant biology of tumor cells with high levels of nuclear EGFR and STAT3.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available